We retrospectively analyzed 901 non‐small‐cell lung cancer patients in the Malaysia Lung Cancer Registry and report on the clinical characteristics associated with programmed death ligand‐1 (PD‐L1) expression and immune checkpoint inhibitor use in Malaysia, a low to middle income country. Here, CD274 is linked to lung cancer.